CWA Calls for ‘Plan B’ on FDA Nomination      8/15/2006

Plan “B,” also known as the morning-after pill, has been making headlines lately as the Food and Drug Administration (FDA) initiates efforts to make the abortion-causing drug available over-the-counter. The driving force behind this is none other than the acting FDA Commissioner Von Eschenback. CWA President Wendy Wright says that as a result of this action, which disregards the health of women and minor girls, Von Eschenback’s nomination to head the FDA should be withdrawn. Click here to listen.

Calls are needed to the White House at 202-456-1111 and to members of the U.S. Senate at 202-224-3121.


More multimedia content.

Printer Friendly Version

Recent Articles

Fetal Homicide: Always Two Victims of Violence

CWALAC Objects to “Ambassador for Abortion” Bill

Pro-Life Activism in the Aftermath of Tiller's Murder

Statement on Killing of Late-Term Abortionist George Tiller

California Supreme Court Yields to “We the People”

New! Research Must Respect Life

Crouse Laments the President’s Spin at Notre Dame

A Solution to the Notre Dame-Obama Conflict

Gallup Shows More Americans Pro-Life

Guest Commentary! Is Obama the First Pro-Euthanasia President?